Biogen (BIIB) Return on Capital Employed (2009 - 2026)

Biogen's Return on Capital Employed history runs 18 years deep, the most recent figure standing at 3.07% for Q1 2026.

• In Q1 2026, Return on Capital Employed fell 24.0% year-over-year to 3.07%; the TTM figure through Mar 2026 stood at 3.07% (down 24.0% YoY), while the FY2025 annual figure was 3.34%, down 149.0% from the prior year.
• Return on Capital Employed was 3.07% for Q1 2026 at Biogen, up from 3.26% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 14.37% in Q2 2022 to a low of 3.26% in Q4 2025.
• Historically, Return on Capital Employed has averaged 2.43% across 5 years, with a median of 2.17% in 2023.
• The sharpest annual moves came in 2022 and 2023: Return on Capital Employed soared 406 bps in 2022, then tumbled 1602 bps in 2023.
• A 5-year view of Return on Capital Employed shows it stood at 12.77% in 2022, then sank by 125 bps to 3.25% in 2023, then soared by 45 bps to 1.79% in 2024, then sank by 83 bps to 3.26% in 2025, then grew by 6 bps to 3.07% in 2026.
• The last three Return on Capital Employed figures came in at 3.07% (Q1 2026), 3.26% (Q4 2025), and 2.31% (Q3 2025), per Business Quant data.